AYVAKIT: payments to doctors
Payments that named AYVAKIT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.7M
- Providers
- 10,855
- Transactions
- 28,980
- Average per transaction
- $163
The per-transaction average — $163 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,855 providers the average total is $434, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Blueprint Medicines Corporation | $3,844,332 | 81.6% |
| Sanofi US Services Inc. | $653,499 | 13.9% |
| Sanofi | $212,581 | 4.5% |